Home » Healthcare » Hospital Infection Therapeutics Market

Hospital Infection Therapeutics Market By Infection Type (Surgical Site Infections (SSI), Central Line-Associated Bloodstream Infections (CLABSI), Catheter-Associated Urinary Tract Infections (CAUTI), Ventilator-Associated Pneumonia (VAP), Clostridium difficile Infections (CDI), Other HAIs) By Treatment Type (Antibiotics, Antivirals, Antifungals, Vaccines, Other Therapies)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Executive Summary

Market Overview

The global Hospital Infection Therapeutics Market has been steadily growing in recent years and is predicted to grow at a 5.00% CAGR between 2023 and 2030. The market is anticipated to be worth USD 13111.4 million by 2030, up from USD 10512.5 million in 2022.

The Hospital Infection Therapeutics Market is a sizable sector of the pharmaceutical and healthcare industries. It is concerned with creating and delivering medications to treat infections that arise in healthcare environments such as hospitals. Several reasons are driving the market, including the rising frequency of hospital-acquired illnesses and increased awareness of the need of infection control methods.

The increased frequency of hospital-acquired infections is one of the primary drivers of the Hospital Infection Therapeutics Market. These infections are dangerous to patients and can result in longer hospital admissions, higher healthcare expenditures, and even death. As a result, there is an increasing need for effective therapies that can cure and prevent these illnesses.

However, there are significant constraints in the market. The growth of antibiotic resistance is one of the major issues. Many hospital-acquired illnesses are caused by microorganisms that have developed antibiotic resistance. This poses a considerable risk to patient health and needs the development of novel therapeutic alternatives.

Despite these obstacles, the Hospital Infection Therapeutics Market offers development potential. There is potential for the development of innovative medications and treatment techniques as technology and research evolve. Furthermore, the growing emphasis on infection control and prevention in hospital settings provides potential for businesses to deliver novel solutions.

Market Definition

The Hospital Infection Therapeutics Market refers to the therapeutics market for infections that arise in healthcare environments such as hospitals. Bacteria, viruses, fungi, and other organisms can cause these diseases, often known as healthcare-associated infections or nosocomial infections. Hospital infections may be dangerous for patients since they are frequently resistant to standard treatments, resulting in problems and increased healthcare expenses. The Hospital Infection Therapeutics Market is concerned with the development and distribution of effective pharmaceuticals and therapies to battle these infections and enhance patient outcomes.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The global demand for Hospital Infection Therapeutics was valued at USD 10512.5 million in 2022 and is expected to reach USD 13111.4 Million in 2030, growing at a CAGR of 5.00% between 2023 and 2030.

Surgical Site Infections (SSIs) lead the hospital therapeutics market in 2022, and urinary tract infections (UTIs) are predicted to grow at the fastest rate.
In 2022, the Antibiotics pharmaceuticals category retained a high market share, while antifungals pharmaceuticals were another key market category.
The intravenous (IV) segment is the most important and topical is another major component in the Hospital Infection Therapeutics Market.
Outpatient Clinics have the highest compound annual growth rate (CAGR) in the industry, and Long-Term Care Facilities are the market’s second largest category.
Exogenous Infections is the fastest expanding area in the Hospital Infection Therapeutics Market, while Endogenous Infections is another key category in the Hospital Infection Therapeutics Market.
The Fungal category was the highest contributor to Hospital-acquired Infection Market revenue in 2022, while Bacterial Infections are another key area in the Hospital Infection Therapeutics Market.
The Pediatrics sector has the largest market share, while Adults are also a significant category in the Hospital Infection Therapeutics Market.
Retail pharmacies have the biggest market demand, and online pharmacies have grown in popularity in recent years.
North America is expected to dominate the market in 2022, accounting for 40% of total revenue, and Asia Pacific is expected to develop at the quickest CAGR throughout the projected period.
Hospital-Acquired Infections (HAIS) Are Becoming More Common promotes market growth
The scarcity of skilled technicians is impeding market growth.

Market Segmentations

Segmentation by Infection Type

In 2022, the Surgical Site Infections (SSIs) category led the Hospital therapeutics market, accounting for 31.8% of total revenue, due to the increased number of surgical operations and associated rising occurrences of SSIs.
During the projection period, the urinary tract infections (UTIs) sector is expected to increase at the quickest rate.

Segmentation by Treatment Type

The Antibiotics Drugs category maintained a significant market share in 2022 and is expected to expand at the quickest CAGR of 5.1% between 2022 and 2027. This is because bacteria cause the vast majority of hospital-acquired infections. As a result, antibiotic treatment is the first line of defence for every sort of hospital-acquired illness.
During the projected period, the antifungals drugs another important category in the market.

Segmentation by Route of Administration

The intravenous (IV) segment is the most important. IV therapies are often used in hospitals to treat serious infections because they allow for the direct and rapid delivery of drugs into the circulation.
Another key component in the Hospital Infection Therapeutics Market is topical.

Segmentation by End-Users

Outpatient Clinics has the greatest Compound Annual Growth Rate (CAGR) in the Hospital Infection Therapeutics Market. As healthcare services continue to expand, there is a rising emphasis on providing care outside of typical hospital settings.
Long-Term Care Facilities is the second largest category in the Hospital Infection Therapeutics Market.

Segmentation by Infection Source

Exogenous Infections is the fastest growing area in the Hospital Infection Therapeutics Market. Exogenous infections are infections acquired from outside sources, such as healthcare settings, community areas, or other people.
Another significant category in the Hospital Infection Therapeutics Market is Endogenous Infections.

Segmentation by Pathogen Type

In 2022, the Fungal category was the largest contributor to the Hospitals-acquired Infection Market revenue. A fungal infection can affect everyone and present in various bodily areas. Fungal infections can be caused by a variety of fungi.
Bacterial Infections are another major area in the Hospital Infection Therapeutics Market.

Segmentation by Patient Age Group

The Pediatrics sector holds the greatest market share. Pediatrics is the branch of medicine concerned with the care of newborns, children, and adolescents. Pediatric infections necessitate particular treatment approaches because their immune systems and physiological responses differ from those of adults.
Adults are another major group in the Hospital Infection Therapeutics Market.

Segmentation by Distribution Channel

Retail Pharmacies have the biggest market demand. Retail pharmacies are generally accessible to the general population and provide a variety of pharmaceutical products and services.
Online pharmacies have grown in popularity in recent years due to the ease and accessibility they provide.

Segmentation by Region

North America led the market in 2022, accounting for 40% of total sales.
During the forecast period, Asia Pacific is expected to develop at the quickest CAGR.
The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Hospital Infection Therapeutics.

North America dominated the hospital infection therapies market in 2022, with the largest market share. Countries in the region with well-established healthcare systems and advanced infrastructure include the United States and Canada. The increasing prevalence of hospital-acquired infections in North America is a major factor driving market expansion. Hospital-acquired infections are a major issue in the region, affecting millions of patients each year. The region’s increasing frequency of antibiotic-resistant illnesses has increased need for effective medicines, adding to North America’s market expansion. This region’s expansion is also being fueled by rising healthcare costs.

The Asia-Pacific Hospital-acquired Infection Market is predicted to develop at the quickest CAGR. The high frequency of HAIs in European countries, as well as the region’s increasing approvals and launches of novel HAI therapeutic medications, explains this dominance. Furthermore, thanks to major firms such as GlaxoSmithKline Plc, the Food and Drug Administration, and others, innovative medicines for hospital-acquired infections are becoming more widely available in European countries. Hoffmann-La Roche A.G. Bayer AG, Allergan Plc, and are also expected to contribute to regional growth.

Key Highlights of the Report

The global Hospital Infection Therapeutics Market is segmented by Infection Type, Treatment Type, Route of Administration, End-User, Infection Source, Pathogen Type, Patient Age Group, Distribution Channel and region. Surgical Site Infections (SSIs) led the Hospital Therapeutics market in 2022. The Pediatrics and Fungal sector dominates the market. Outpatient Clinics also have the highest compound annual growth rate (CAGR) in the industry, while Retail Pharmacies have the highest market demand. Exogenous Infections, on the other hand, are the fastest expanding segment of the Hospital Infection Therapeutics Market, with North America leading the market growth.

The primary drivers of the market are the increasing frequency of hospital-acquired illnesses, growing awareness of the necessity of infection control measures, and advancements in technology and research. In addition, the market is confronted with critical hurdles such as the emergence of antibiotic resistance, the high cost of researching and manufacturing novel treatments, stringent regulatory requirements, and limited access to healthcare facilities in some countries.

Nonetheless, With the biggest market share in 2022, North America led the hospital infection treatments market. The United States and Canada are two countries in the region with well-established healthcare systems and modern infrastructure. Furthermore, the Asia-Pacific Hospital-acquired Infection Market is expected to grow at the fastest CAGR.

What Factors Are Fueling The Growth Of The Global Hospital Infection Therapeutics Market?

The rising frequency of hospital-acquired infections is one of the primary drivers of the Hospital Infection Therapeutics Market. These infections offer a considerable danger to patients, resulting in an increased demand for effective medicines to treat and prevent them. Furthermore, healthcare professionals and the general public are becoming more aware of the need of infection control measures in hospital settings. This heightened awareness has pushed the desire for infection treatments even more.

What Are The Key Challenges Encountered By The Global Hospital Infection Therapeutics Market?

The Hospital Infection Therapeutics Market is hampered by a number of factors. The advent of antibiotic resistance is a big concern. Many hospital-acquired illnesses are caused by microorganisms that have developed antibiotic resistance. This is a serious hazard to patient health and necessitates the development of novel therapeutic alternatives. Furthermore, the high cost of developing and producing novel treatments might be a barrier for firms in this sector.

What Opportunities For Growth Exist In The Global Hospital Infection Therapeutics Market?

Despite the obstacles, the Hospital Infection Therapeutics Market provides potential prospects. There is potential for the development of innovative medications and treatment techniques as technology and research evolve. The growing need for efficient infection control solutions opens up new potential for businesses to provide innovative goods and services.

Market Drivers

The global Hospital Infection Therapeutics Market is driven by several factors. The following are the key drivers of the global Hospital Infection Therapeutics Market:

Hospital-Acquired Infections (HAIS) Are Becoming More Common

Infections acquired during hospitalization, frequently as a result of exposure to pathogens such as bacteria, viruses, or fungi, are referred to as hospital-acquired infections. These infections can be difficult to treat and, in some circumstances, can result in serious consequences or even death. HAIs affect hundreds of millions of people globally each year, causing significant morbidity, mortality, and economic burden, according to the World Health Organization (WHO).

The Centres for Disease Control and Prevention (CDC) estimates that approximately one in every 31 hospital patients in the United States has a HAI, resulting in tens of thousands of fatalities and billions of dollars in additional healthcare expenses each year. As a result, there is an increasing demand for effective HAI treatments and prevention measures.

Demand For Modern Healthcare Facilities Is Increasing

As healthcare facilities change and improve, so does the demand for sophisticated hospital infection therapies. Hospitals and other healthcare institutions are investing in sophisticated infection control technology and solutions, which need the use of advanced therapies. Furthermore, as the need for minimally invasive surgeries and procedures grows, so does the demand for hospital infection treatments, as these procedures pose a high risk of infection.

Market Restraints

The global Hospital Infection Therapeutics Market faces some challenges that may hinder its growth. These include the following:

Shortage Of Skilled Technicians

The hospital, clinical laboratory, and diagnostic centre network spans the globe. As the world’s population grows, so does the demand on the healthcare system to provide efficient care. Some issues impeding the expansion of the healthcare sector include significant investment in infrastructure, equipment, and machinery, as well as a shortage of skilled professionals. According to the WHO, the global workforce in healthcare will be reduced by 12.9 million by 2035. The global shortage of healthcare personnel is caused by a number of factors, including an aging workforce, a decline in the number of people entering the profession, early retirements, inadequate training, and increased demands from a growing and aging population, all of which will impede market growth over the forecast period.

Opportunities

The global Hospital Infection Therapeutics Market offers significant growth opportunities. These include the following:

Technological Advancement

The hospital infection therapeutics market is likely to benefit from technological developments in diagnostics, drug delivery, and therapy monitoring. For example, the development of rapid diagnostic tests and point-of-care devices assists healthcare personnel in swiftly diagnosing and treating hospital-acquired infections, resulting in better patient outcomes and a lower risk of infection transmission.

Moreover, telemedicine and digital health platforms offer remote monitoring of patients with hospital-acquired infections and increase patient access to healthcare services. Furthermore, the development of innovative drug delivery technologies, such as nanoparticles and liposomes, improves treatment efficacy and minimizes toxicity, increasing the effectiveness of hospital infection therapy.

Competitive Landscape

Key Players

The global Hospital Infection Therapeutics Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Merck & Co., Inc.
Pfizer Inc.
Bayer AG
GlaxoSmithKline Plc.
Daiichi Sankyo Company, Limited
AbbVie Inc.
Abbott Laboratories
F. Hoffmann-La Roche Ltd
Allergan Plc.
Johnson & Johnson
Bristol-Myers Squibb Company
Cubist Pharmaceuticals, Inc

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Hospital Infection Therapeutics Market’s key players continually seek to stay ahead by offering new Infection Types and developments.

In March 2023, Cefazolin for Injection was introduced by Hikma Pharmaceuticals PLC. The medication is meant to treat bacterial infections in the urinary tract, skin, respiratory tract, lining of heart chambers and heart valves, joint, genital, bone, blood, and biliary tract, as well as for perioperative prophylaxis.

In January 2023, Alkem introduced Zidavi, an antibiotic that combines ceftazidime and avibactam. The medication is designed to treat hospital-acquired pneumonia (HAP) and complex intra-abdominal infections (IAIs).

In April 2022, Pfizer has agreed to buy ReViral, a clinical-stage biopharmaceutical business focusing on developing antiviral medicines for respiratory syncytial virus (RSV). The acquisition will help Pfizer extend its antiviral pharmaceuticals business and support its attempts to develop novel therapies for RSV and other respiratory illnesses.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

A skilled technician shortage is impeding market growth.

Market segmented by Infection Type, Treatment Type, Route of Administration, End-User, Infection Source, Pathogen Type, Patient Age Group, Distribution Channel and region.
The Fungal category was the highest contributor to Hospital-acquired Infection Market
Exogenous Infections is the fastest expanding area in the Hospital Infection Therapeutics Market
North America is leading market growth; the market is highly competitive with key players including Merck & Co., Inc.; Pfizer Inc.; Bayer AG; GlaxoSmithKline Plc.; Daiichi Sankyo Company, Limited; AbbVie Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Allergan Plc.

Future Outlook

Government measures and growing healthcare costs will drive market expansion.
Antibiotic resistance will stimulate the development of new therapeutic methods.
Rising infection prevention awareness will boost demand for medicines.
As healthcare infrastructure in poorer countries expands, new possibilities will emerge.
The use of digital health technology improves patient outcomes.
Strict regulatory rules will define the market environment.

Segmentation

By Infection Type:
- Surgical Site Infections (SSI)
- Central Line-Associated Bloodstream Infections (CLABSI)
- Catheter-Associated Urinary Tract Infections (CAUTI)
- Ventilator-Associated Pneumonia (VAP)
- Clostridium difficile Infections (CDI)
- Other HAIs
By Treatment Type:
- Antibiotics
- Antivirals
- Antifungals
- Vaccines
- Other Therapies
By Route of Administration:
- Oral
- Intravenous (IV)
- Topical
- Others
By End-users:
- Hospitals: Healthcare
- Long-Term Care Facilities
- Outpatient Clinics
- Others
By Infection Source:
- Exogenous Infections
- Endogenous Infections
By Pathogen Type:
- Bacterial Infections
- Viral Infections
- Fungal Infections
- Other Pathogens
By Patient Age Group:
- Adults
- Pediatrics
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
  - U.S
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - U.K.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of Middle East and Africa

Adjacent Markets

In the Hospital Infection Therapeutics Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Hospital Infection Therapeutics Market-

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

2. Executive Summary

2.1. Market Snapshot: Global Hospital Infection Therapeutics Market

2.1.1. Global Hospital Infection Therapeutics Market, By Infection Type

2.1.2. Global Hospital Infection Therapeutics Market, By Treatment Type

2.1.3. Global Hospital Infection Therapeutics Market, By Route of Administration

2.1.4. Global Hospital Infection Therapeutics Market, By End-Users

2.1.5. Global Hospital Infection Therapeutics Market, By Infection Source

2.1.6. Global Hospital Infection Therapeutics Market, By Pathogen Type

2.1.7. Global Hospital Infection Therapeutics Market, By Patient Age Group

2.1.8. Global Hospital Infection Therapeutics Market, By Distribution Channels

2.1.9. Global Hospital Infection Therapeutics Market, By Region

2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Hospital Infection Therapeutics Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Hospital Infection Therapeutics Market Drivers

3.2.2. Hospital Infection Therapeutics Market Restraints

3.2.3. Hospital Infection Therapeutics Market Opportunities

3.2.4. Major Hospital Infection Therapeutics Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Infection Type

3.5.2. Treatment Type

3.5.3. Route of Administration

3.5.4. End-Users

3.5.5. Infection Source

3.5.6. Pathogen Type

3.5.7. Patient Age Group

3.5.8. Distribution Channels

3.5.9. Geography

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Hospital Infection Therapeutics Market: Company Market Share, Value 2022

4.1.2. Global Hospital Infection Therapeutics Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Hospital Infection Therapeutics Market: Top 3 Company Market Share, Value 2022

4.2. Global Hospital Infection Therapeutics Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Hospital Infection Therapeutics Market

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Hospital Infection Therapeutics Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

8. Global Hospital Infection Therapeutics Market, By Infection Type

8.1. Global Hospital Infection Therapeutics Market Overview, by Infection Type

8.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Infection Type, 2022 Vs 2030 (in %)

8.2. Surgical Site Infections (SSI)

8.2.1. Global Hospital Infection Therapeutics Market, By Surgical Site Infections (SSI), By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for Surgical Site Infections (SSI)

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Central Line-Associated Bloodstream Infections (CLABSI)

8.3.1. Global Hospital Infection Therapeutics Market, By Central Line-Associated Bloodstream Infections (CLABSI), By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for Central Line-Associated Bloodstream Infections (CLABSI)

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

9. Global Hospital Infection Therapeutics Market, By Treatment Types

9.1. Global Hospital Infection Therapeutics Market Overview, By Treatment Types

9.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Treatment Types, 2022 Vs 2030 (in %)

9.2. Antibiotics

9.2.1. Global Hospital Infection Therapeutics Market, By Antibiotics, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Antibiotics

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Antivirals

9.3.1. Global Hospital Infection Therapeutics Market, By Antivirals, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Antivirals

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Antifungals

9.4.1. Global Hospital Infection Therapeutics Market, By Antifungals, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Antifungals

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

9.5. Vaccines

9.5.1. Global Hospital Infection Therapeutics Market, By Vaccines, By Region, 2017-2030 (US$ Mn)

9.5.2. Market Dynamics for Vacciness

9.5.2.1. Drivers

9.5.2.2. Restraints

9.5.2.3. Opportunities

9.5.2.4. Trends

10. Global Hospital Infection Therapeutics Market, By Route of Administration

10.1. Global Hospital Infection Therapeutics Market Overview, by Route of Administration

10.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Route of Administration, 2022 Vs 2030 (in %)

10.2. Oral

10.2.1. Global Hospital Infection Therapeutics Market, By Oral, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Oral

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Intravenous (IV)

10.3.1. Global Hospital Infection Therapeutics Market, By Intravenous (IV), By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Intravenous (IV)

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

11. Global Hospital Infection Therapeutics Market, By End-Users

11.1. Global Hospital Infection Therapeutics Market Overview, by End-Users

11.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By End-Users, 2022 Vs 2030 (in %)

11.2. Adults: Healthcare

11.2.1. Global Hospital Infection Therapeutics Market, By Adults: Healthcare, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Adults: Healthcare

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Long-Term Care Facilities

11.3.1. Global Hospital Infection Therapeutics Market, By Long-Term Care Facilities, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Long-Term Care Facilities

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

11.4. Outpatient Clinics

11.4.1. Global Hospital Infection Therapeutics Market, By Outpatient Clinics, By Region, 2017-2030 (US$ Mn)

11.4.2. Market Dynamics for Outpatient Clinics

11.4.2.1. Drivers

11.4.2.2. Restraints

11.4.2.3. Opportunities

11.4.2.4. Trends

12. Global Hospital Infection Therapeutics Market, By Infection Source

12.1. Global Hospital Infection Therapeutics Market Overview, by Infection Source

12.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Infection Source, 2022 Vs 2030 (in %)

12.2. Exogenous Infections

12.2.1. Global Hospital Infection Therapeutics Market, By Exogenous Infections, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Exogenous Infections

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Endogenous Infections

12.3.1. Global Hospital Infection Therapeutics Market, By Endogenous Infections, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Endogenous Infections

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

13. Global Hospital Infection Therapeutics Market, By Pathogen Type

13.1. Global Hospital Infection Therapeutics Market Overview, by Pathogen Type

13.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Pathogen Type, 2022 Vs 2030 (in %)

13.2. Bacterial Infections

13.2.1. Global Hospital Infection Therapeutics Market, By Bacterial Infections, By Region, 2017-2030 (US$ Mn)

13.2.2. Market Dynamics for Bacterial Infections

13.2.2.1. Drivers

13.2.2.2. Restraints

13.2.2.3. Opportunities

13.2.2.4. Trends

13.3. Viral Infections

13.3.1. Global Hospital Infection Therapeutics Market, By Viral Infections, By Region, 2017-2030 (US$ Mn)

13.3.2. Market Dynamics for Viral Infections

13.3.2.1. Drivers

13.3.2.2. Restraints

13.3.2.3. Opportunities

13.3.2.4. Trends

13.4. Fungal Infections

13.4.1. Global Hospital Infection Therapeutics Market, By Fungal Infections, By Region, 2017-2030 (US$ Mn)

13.4.2. Market Dynamics for Fungal Infections

13.4.2.1. Drivers

13.4.2.2. Restraints

13.4.2.3. Opportunities

13.4.2.4. Trends

13.5. Other Pathogens

13.5.1. Global Hospital Infection Therapeutics Market, By Other Pathogens, By Region, 2017-2030 (US$ Mn)

13.5.2. Market Dynamics for Other Pathogens

13.5.2.1. Drivers

13.5.2.2. Restraints

13.5.2.3. Opportunities

13.5.2.4. Trends

14. Global Hospital Infection Therapeutics Market, By Patient Age Group

14.1. Global Hospital Infection Therapeutics Market Overview, by Patient Age Group

14.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Patient Age Group, 2022 Vs 2030 (in %)

14.2. Adults

14.2.1. Global Hospital Infection Therapeutics Market, By Adults, By Region, 2017-2030 (US$ Mn)

14.2.2. Market Dynamics for Adults

14.2.2.1. Drivers

14.2.2.2. Restraints

14.2.2.3. Opportunities

14.2.2.4. Trends

14.3. Pediatrics

14.3.1. Global Hospital Infection Therapeutics Market, By Pediatrics, By Region, 2017-2030 (US$ Mn)

14.3.2. Market Dynamics for Pediatrics

14.3.2.1. Drivers

14.3.2.2. Restraints

14.3.2.3. Opportunities

14.3.2.4. Trends

15. Global Hospital Infection Therapeutics Market, By Distribution Channel

15.1. Global Hospital Infection Therapeutics Market Overview, by Distribution Channel

15.1.1. Global Hospital Infection Therapeutics Market Revenue Share, By Distribution Channel, 2022 Vs 2030 (in %)

15.2. Hospital Pharmacies

15.2.1. Global Hospital Infection Therapeutics Market, By Hospital Pharmacies, By Region, 2017-2030 (US$ Mn)

15.2.2. Market Dynamics for Hospital Pharmacies

15.2.2.1. Drivers

15.2.2.2. Restraints

15.2.2.3. Opportunities

15.2.2.4. Trends

15.3. Retail Pharmacies

15.3.1. Global Hospital Infection Therapeutics Market, By Retail Pharmacies, By Region, 2017-2030 (US$ Mn)

15.3.2. Market Dynamics for Retail Pharmacies

15.3.2.1. Drivers

15.3.2.2. Restraints

15.3.2.3. Opportunities

15.3.2.4. Trends

16. Global Hospital Infection Therapeutics Market, By Region

16.1. Global Hospital Infection Therapeutics Market Overview, by Region

16.1.1. Global Hospital Infection Therapeutics Market, By Region, 2022 vs 2030 (in%)

16.2. Infection Type

16.2.1. Global Hospital Infection Therapeutics Market, By Infection Type, 2017-2030 (US$ Mn)

16.3. Treatment Type

16.3.1. Global Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030 (US$ Mn)

16.4. Route of Administration

16.4.1. Global Hospital Infection Therapeutics Market, By Route of Administration, 2017-2030 (US$ Mn)

16.5. End-Users

16.5.1. Global Hospital Infection Therapeutics Market, By End-Users, 2017-2030 (US$ Mn)

16.6. Infection Source

16.6.1. Global Hospital Infection Therapeutics Market, By Infection Source, 2017-2030 (US$ Mn)

16.7. Pathogen Type

16.7.1. Global Hospital Infection Therapeutics Market, By Pathogen Type, 2017-2030 (US$ Mn)

16.8. Patient Age Group

16.8.1. Global Hospital Infection Therapeutics Market, By Patient Age Group, 2017-2030 (US$ Mn)

16.9. Distribution Channel

16.9.1. Global Hospital Infection Therapeutics Market, By Patient Age Group, 2017-2030 (US$ Mn)

17. North America Hospital Infection Therapeutics Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. North America Hospital Infection Therapeutics Market, by Infection Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. North America Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. North America Hospital Infection Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. North America Hospital Infection Therapeutics Market, by End-Users, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. North America Hospital Infection Therapeutics Market, by Infection Source, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. North America Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2030(US$ Mn)

17.7.1. Overview

17.7.2. SRC Analysis

17.8. North America Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2030(US$ Mn)

17.8.1. Overview

17.8.2. SRC Analysis

17.9. North America Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2030(US$ Mn)

17.9.1. Overview

17.9.2. SRC Analysis

17.10. North America Hospital Infection Therapeutics Market, by Country, 2017-2030(US$ Mn)

17.10.1. North America Hospital Infection Therapeutics Market, by Country, 2022 Vs 2030 (in%)

17.10.2. U.S.

17.10.3. Canada

17.10.4. Mexico

18. Europe Hospital Infection Therapeutics Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Europe Hospital Infection Therapeutics Market, by Infection Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Europe Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Europe Hospital Infection Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Europe Hospital Infection Therapeutics Market, by End-Users, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Europe Hospital Infection Therapeutics Market, by Infection Source, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Europe Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2030(US$ Mn)

18.7.1. Overview

18.7.2. SRC Analysis

18.8. Europe Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2030(US$ Mn)

18.8.1. Overview

18.8.2. SRC Analysis

18.9. Europe Hospital Infection Therapeutics Market, by Distribution channel, 2017-2030(US$ Mn)

18.9.1. Overview

18.9.2. SRC Analysis

18.10. Europe Hospital Infection Therapeutics Market, by Country, 2017-2030 (US$ Mn)

18.10.1. Europe Hospital Infection Therapeutics Market, by Country, 2022 Vs 2030 (in%)

18.10.2. UK

18.10.3. France

18.10.4. Germany

18.10.5. Italy

18.10.6. Spain

18.10.7. Benelux

18.10.8. Russia

18.10.9. Rest of Europe

19. Asia Pacific Hospital Infection Therapeutics Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Asia Pacific Hospital Infection Therapeutics Market, by Infection Type, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Asia Pacific Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Asia Pacific Hospital Infection Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Asia Pacific Hospital Infection Therapeutics Market, by End-Users, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Asia Pacific Hospital Infection Therapeutics Market, by Infection Source, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Asia Pacific Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2030(US$ Mn)

19.7.1. Overview

19.7.2. SRC Analysis

19.8. Asia Pacific Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2030(US$ Mn)

19.8.1. Overview

19.8.2. SRC Analysis

19.9. Asia Pacific Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2030(US$ Mn)

19.9.1. Overview

19.9.2. SRC Analysis

19.10. Asia Pacific Hospital Infection Therapeutics Market, by Country, 2017-2030 (US$ Mn)

19.10.1. Asia Pacific Hospital Infection Therapeutics Market, by Country, 2022 Vs 2030 (in%)

19.10.2. China

19.10.3. Japan

19.10.4. India

19.10.5. South Korea

19.10.6. South East Asia

19.10.7. Rest of Asia Pacific

20. Latin America Hospital Infection Therapeutics Market Analysis

20.1. Overview

20.1.1. Market Dynamics for North America

20.1.1.1. Drivers

20.1.1.2. Restraints

20.1.1.3. Opportunities

20.1.1.4. Trends

20.2. Latin America Hospital Infection Therapeutics Market, by Infection Type, 2017-2030(US$ Mn)

20.2.1. Overview

20.2.2. SRC Analysis

20.3. Latin America Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030(US$ Mn)

20.3.1. Overview

20.3.2. SRC Analysis

20.4. Latin America Hospital Infection Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

20.4.1. Overview

20.4.2. SRC Analysis

20.5. Latin America Hospital Infection Therapeutics Market, by End-Users, 2017-2030(US$ Mn)

20.5.1. Overview

20.5.2. SRC Analysis

20.6. Latin America Hospital Infection Therapeutics Market, by Infection Source, 2017-2030(US$ Mn)

20.6.1. Overview

20.6.2. SRC Analysis

20.7. Latin America Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2030(US$ Mn)

20.7.1. Overview

20.7.2. SRC Analysis

20.8. Latin America Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2030(US$ Mn)

20.8.1. Overview

20.8.2. SRC Analysis

20.9. Latin America Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2030(US$ Mn)

20.9.1. Overview

20.9.2. SRC Analysis

20.10. Latin America Hospital Infection Therapeutics Market, by Country, 2017-2030 (US$ Mn)

20.10.1. Latin America Hospital Infection Therapeutics Market, by Country, 2022 Vs 2030 (in%)

20.10.2. Brazil

20.10.3. Argentina

20.10.4. Rest of Latin America

21. Middle East Hospital Infection Therapeutics Market Analysis

21.1. Overview

21.1.1. Market Dynamics for North America

21.1.1.1. Drivers

21.1.1.2. Restraints

21.1.1.3. Opportunities

21.1.1.4. Trends

21.2. Middle East Hospital Infection Therapeutics Market, by Infection Type, 2017-2030(US$ Mn)

21.2.1. Overview

21.2.2. SRC Analysis

21.3. Middle East Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030(US$ Mn)

21.3.1. Overview

21.3.2. SRC Analysis

21.4. Middle East Hospital Infection Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

21.4.1. Overview

21.4.2. SRC Analysis

21.5. Middle East Hospital Infection Therapeutics Market, by End-Users, 2017-2030(US$ Mn)

21.5.1. Overview

21.5.2. SRC Analysis

21.6. Middle East Hospital Infection Therapeutics Market, by Infection Source, 2017-2030(US$ Mn)

21.6.1. Overview

21.6.2. SRC Analysis

21.7. Middle East Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2030(US$ Mn)

21.7.1. Overview

21.7.2. SRC Analysis

21.8. Middle East Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2030(US$ Mn)

21.8.1. Overview

21.8.2. SRC Analysis

21.9. Middle East Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2030(US$ Mn)

21.9.1. Overview

21.9.2. SRC Analysis

21.10. Middle East Hospital Infection Therapeutics Market, by Country, 2017-2030 (US$ Mn)

21.10.1. Middle East Hospital Infection Therapeutics Market, by Country, 2022 Vs 2030 (in%)

21.10.2. UAE

21.10.3. Saudi Arabia

21.10.4. Rest of Middle East

22. Africa Hospital Infection Therapeutics Market Analysis

22.1. Overview

22.1.1. Market Dynamics for North America

22.1.1.1. Drivers

22.1.1.2. Restraints

22.1.1.3. Opportunities

22.1.1.4. Trends

22.2. Africa Hospital Infection Therapeutics Market, by Infection Type, 2017-2030(US$ Mn)

22.2.1. Overview

22.2.2. SRC Analysis

22.3. Africa Hospital Infection Therapeutics Market, By Treatment Type, 2017-2030(US$ Mn)

22.3.1. Overview

22.3.2. SRC Analysis

22.4. Africa Hospital Infection Therapeutics Market, by Route of Administration, 2017-2030(US$ Mn)

22.4.1. Overview

22.4.2. SRC Analysis

22.5. Africa Hospital Infection Therapeutics Market, by End-Users, 2017-2030(US$ Mn)

22.5.1. Overview

22.5.2. SRC Analysis

22.6. Africa Hospital Infection Therapeutics Market, by Infection Source, 2017-2030(US$ Mn)

22.6.1. Overview

22.6.2. SRC Analysis

22.7. Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2030(US$ Mn)

22.7.1. Overview

22.7.2. SRC Analysis

22.8. Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2030(US$ Mn)

22.8.1. Overview

22.8.2. SRC Analysis

22.9. Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2030(US$ Mn)

22.9.1. Overview

22.9.2. SRC Analysis

22.10. Africa Hospital Infection Therapeutics Market, by Country, 2017-2030 (US$ Mn)

22.10.1. Middle East Hospital Infection Therapeutics Market, by Country, 2022 Vs 2030 (in%)

22.10.2. South Africa

22.10.3. Egypt

22.10.4. Rest of Africa

23. Company Profiles

23.1. Merck & Co., Inc.

23.1.1. Company Overview

23.1.2. Products/Services Portfolio

23.1.3. Geographical Presence

23.1.4. SWOT Analysis

23.1.5. Financial Summary

23.1.5.1. Market Revenue and Net Profit (2019-2022)

23.1.5.2. Business Segment Revenue Analysis

23.1.5.3. Geographical Revenue Analysis

23.2. Pfizer Inc.

23.3. Bayer AG

23.4. GlaxoSmithKline Plc.

23.5. Daiichi Sankyo Company, Limited

23.6. AbbVie Inc.

23.7. Abbott Laboratories

23.8. F. Hoffmann-La Roche Ltd

23.9. Allergan Plc.

23.10. Johnson & Johnson

23.11. Bristol-Myers Squibb Company

23.12. Cubist Pharmaceuticals, Inc

24. Research Methodology

24.1. Research Methodology

24.2. Phase I – Secondary Research

24.3. Phase II – Data Modelling

24.3.1. Company Share Analysis Model

24.3.2. Revenue Based Modelling

24.4. Phase III – Primary Research

24.5. Research Limitations

24.5.1. Assumptions

List of Figures

FIG. 1 Global Hospital Infection Therapeutics Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Hospital Infection Therapeutics Market Segmentation

FIG. 4 Global Hospital Infection Therapeutics Market, by Infection Type, 2022 (US$ Mn)

FIG. 5 Global Hospital Infection Therapeutics Market, By Treatment Type, 2022 (US$ Mn)

FIG. 6 Global Hospital Infection Therapeutics Market, by Route of Administration, 2022 (US$ Mn)

FIG. 7 Global Hospital Infection Therapeutics Market, by Data Trasnfer Speed, 2022 (US$ Mn)

FIG. 8 Global Hospital Infection Therapeutics Market, by Infection Source, 2022 (US$ Mn)

FIG. 9 Global Hospital Infection Therapeutics Market, by Pathogen Type, 2022 (US$ Mn)

FIG. 10 Global Hospital Infection Therapeutics Market, by Patient Age Group, 2022 (US$ Mn)

FIG. 11 Global Hospital Infection Therapeutics Market, by Distribution Channel, 2022 (US$ Mn)

FIG. 12 Global Hospital Infection Therapeutics Market, by Geography, 2022 (US$ Mn)

FIG. 13 Attractive Investment Proposition, by Infection Type, 2022

FIG. 14 Attractive Investment Proposition, By Treatment Type, 2022

FIG. 15 Attractive Investment Proposition, by Route of Administration, 2022

FIG. 16 Attractive Investment Proposition, by End-Users, 2022

FIG. 17 Attractive Investment Proposition, by Infection Source, 2022

FIG. 18 Attractive Investment Proposition, by Pathogen Type, 2022

FIG. 19 Attractive Investment Proposition, by Patient Age Group, 2022

FIG. 20 Attractive Investment Proposition, by Distribution Channel, 2022

FIG. 21 Attractive Investment Proposition, by Geography, 2022

FIG. 22 Global Market Share Analysis of Key Hospital Infection Therapeutics Market Manufacturers, 2022

FIG. 23 Global Market Positioning of Key Hospital Infection Therapeutics Market Manufacturers, 2022

FIG. 24 Global Hospital Infection Therapeutics Market Value Contribution, By Infection Type, 2022 & 2030 (Value %)

FIG. 25 Global Hospital Infection Therapeutics Market, by Surgical Site Infections (SSI), Value, 2017-2030 (US$ Mn)

FIG. 26 Global Hospital Infection Therapeutics Market, by Central Line-Associated Bloodstream Infections (CLABSI), Value, 2017-2030 (US$ Mn)

FIG. 27 Global Hospital Infection Therapeutics Market Value Contribution, By Treatment Type, 2022 & 2030 (Value %)

FIG. 28 Global Hospital Infection Therapeutics Market, by Antibiotics, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Hospital Infection Therapeutics Market, by Antivirals, Value, 2017-2030 (US$ Mn)

FIG. 30 Global Hospital Infection Therapeutics Market, by Antifungals, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Hospital Infection Therapeutics Market, by Vacciness, Value, 2017-2030 (US$ Mn)

FIG. 32 Global Hospital Infection Therapeutics Market Value Contribution, By Route of Administration, 2022 & 2030 (Value %)

FIG. 33 Global Hospital Infection Therapeutics Market, by Oral, Value, 2017-2030 (US$ Mn)

FIG. 34 Global Hospital Infection Therapeutics Market, by Intravenous (IV), Value, 2017-2030 (US$ Mn)

FIG. 35 Global Hospital Infection Therapeutics Market Value Contribution, By End-Users, 2022 & 2030 (Value %)

FIG. 36 Global Hospital Infection Therapeutics Market, by Adults: Healthcare, Value, 2017-2030 (US$ Mn)

FIG. 37 Global Hospital Infection Therapeutics Market, by Long-Term Care Facilities, Value, 2017-2030 (US$ Mn)

FIG. 38 Global Hospital Infection Therapeutics Market, by Outpatient Clinics, Value, 2017-2030 (US$ Mn)

FIG. 39 Global Hospital Infection Therapeutics Market Value Contribution, By Infection Source, 2022 & 2030 (Value %)

FIG. 40 Global Hospital Infection Therapeutics Market, by Exogenous Infections, Value, 2017-2030 (US$ Mn)

FIG. 41 Global Hospital Infection Therapeutics Market, by Endogenous Infections, Value, 2017-2030 (US$ Mn)

FIG. 42 Global Hospital Infection Therapeutics Market Value Contribution, By Pathogen Type, 2022 & 2030 (Value %)

FIG. 43 Global Hospital Infection Therapeutics Market, by Bacterial Infections, Value, 2017-2030 (US$ Mn)

FIG. 44 Global Hospital Infection Therapeutics Market, by Viral Infections, Value, 2017-2030 (US$ Mn)

FIG. 45 Global Hospital Infection Therapeutics Market, by Fungal Infections, Value, 2017-2030 (US$ Mn)

FIG. 46 Global Hospital Infection Therapeutics Market, by Other Pathogens, Value, 2017-2030 (US$ Mn)

FIG. 47 Global Hospital Infection Therapeutics Market Value Contribution, By Patient Age Group, 2022 & 2030 (Value %)

FIG. 48 Global Hospital Infection Therapeutics Market, by Adults, Value, 2017-2030 (US$ Mn)

FIG. 49 Global Hospital Infection Therapeutics Market, by Pediatrics, Value, 2017-2030 (US$ Mn)

FIG. 50 Global Hospital Infection Therapeutics Market, by Ambulatory Surgical Centers, Value, 2017-2030 (US$ Mn)

FIG. 51 Global Hospital Infection Therapeutics Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)

FIG. 52 Global Hospital Infection Therapeutics Market, by Hospital Pharmacies, Value, 2017-2030 (US$ Mn)

FIG. 53 Global Hospital Infection Therapeutics Market, by Retail Pharmacies, Value, 2017-2030 (US$ Mn)

FIG. 54 North America Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 55 U.S. Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 56 Canada Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 57 Mexico Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 58 Europe Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 59 Germany Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 60 France Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 61 U.K. Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 62 Italy Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 63 Spain Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 64 Benelux Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 65 Russia Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 66 Rest of Europe Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 67 Asia Pacific Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 68 China Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 69 Japan Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 70 India Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 71 South Korea Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 72 South-East Asia Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 73 Rest of Asia Pacific Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 74 Latin America Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 75 Brazil Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 76 Argentina Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 77 Rest of Latin America Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 78 Middle East Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 79 UAE Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 80 Saudi Arabia Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 81 Rest of Middle East Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 82 Africa Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 83 South Africa Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 84 Egypt Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

FIG. 85 Rest of Africa Hospital Infection Therapeutics Market, 2017-2030 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Hospital Infection Therapeutics Market

TABLE 2 Global Hospital Infection Therapeutics Market: Market Drivers Impact Analysis

TABLE 3 Global Hospital Infection Therapeutics Market: Market Restraints Impact Analysis

TABLE 4 Global Hospital Infection Therapeutics Market, by Competitive Benchmarking, 2022

TABLE 5 Global Hospital Infection Therapeutics Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Hospital Infection Therapeutics Market, by Key Strategies Analysis, 2022

TABLE 7 Global Hospital Infection Therapeutics Market, by SURGICAL SITE INFECTIONS (SSI), By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Hospital Infection Therapeutics Market, by SURGICAL SITE INFECTIONS (SSI), By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Hospital Infection Therapeutics Market, by CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS (CLABSI), By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Hospital Infection Therapeutics Market, by CENTRAL LINE-ASSOCIATED BLOODSTREAM INFECTIONS (CLABSI), By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Hospital Infection Therapeutics Market, by Antibiotics, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Hospital Infection Therapeutics Market, by Antibiotics, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Hospital Infection Therapeutics Market, by Antivirals, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Hospital Infection Therapeutics Market, by Antivirals, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Hospital Infection Therapeutics Market, by Antifungals, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Hospital Infection Therapeutics Market, by Antifungals, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Hospital Infection Therapeutics Market, by Vaccines, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Hospital Infection Therapeutics Market, by Vaccines, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Hospital Infection Therapeutics Market, by Oral, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Hospital Infection Therapeutics Market, by Oral, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Hospital Infection Therapeutics Market, by Intravenous (IV), By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Hospital Infection Therapeutics Market, by Intravenous (IV), By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Hospital Infection Therapeutics Market, by Adults , By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Hospital Infection Therapeutics Market, by Adults, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Hospital Infection Therapeutics Market, by Pediatrics-speed Interface, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Hospital Infection Therapeutics Market, by Pediatrics-speed Interface, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Hospital Infection Therapeutics Market, by Ambulatory Surgical Centers-speed Interface, By Region, 2017-2022 (US$ Mn)

TABLE 28 Global Hospital Infection Therapeutics Market, by Ambulatory Surgical Centers-speed Interface, By Region, 2023-2030 (US$ Mn)

TABLE 29 ,

TABLE 30 Global Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 31 Global Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 32 Global Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 33 Global Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 34 Global Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 35 Global Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 36 Global Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 37 Global Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 38 Global Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 39 Global Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 40 Global Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 41 Global Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 42 Global Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 43 Global Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 44 Global Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 45 Global Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 46 Global Hospital Infection Therapeutics Market, by Region, 2017-2022 (US$ Mn)

TABLE 47 Global Hospital Infection Therapeutics Market, by Region, 2023-2030 (US$ Mn)

TABLE 48 North America Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 49 North America Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 50 North America Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 51 North America Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 52 North America Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 53 North America Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 54 North AmericaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 55 North AmericaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 56 North AmericaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 57 North AmericaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 58 North AmericaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 59 North AmericaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 60 North AmericaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 61 North AmericaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 62 North AmericaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 63 North AmericaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 64 North America Hospital Infection Therapeutics Market, by Country, 2017-2022 (US$ Mn)

TABLE 65 North America Hospital Infection Therapeutics Market, by Country, 2023-2030 (US$ Mn)

TABLE 66 United States Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 67 United States Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 68 United States Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 69 United States Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 70 United States Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 71 United States Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 72 United StatesHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 73 United StatesHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 74 United StatesHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 75 United StatesHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 76 United StatesHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 77 United StatesHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 78 United StatesHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 79 United StatesHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 80 United StatesHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 81 United StatesHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 82 Canada Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 83 Canada Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 84 Canada Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 85 Canada Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 86 Canada Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 87 Canada Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 88 CanadaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 89 CanadaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 90 CanadaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 91 CanadaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 92 CanadaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 93 CanadaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 94 CanadaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 95 CanadaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 96 CanadaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 97 CanadaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 98 Mexico Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 99 Mexico Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 100 Mexico Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 101 Mexico Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 102 Mexico Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 103 Mexico Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 104 MexicoHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 105 MexicoHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 106 MexicoHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 107 MexicoHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 108 MexicoHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 109 MexicoHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 110 MexicoHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 111 MexicoHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 112 MexicoHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 113 MexicoHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 114 Europe Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 115 Europe Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 116 Europe Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 117 Europe Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 118 Europe Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 119 Europe Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 120 Europe Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 121 Europe Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 122 Europe Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 123 Europe Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 124 Europe Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 125 Europe Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 126 Europe Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 127 Europe Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 128 Europe Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 129 Europe Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 130 Europe Hospital Infection Therapeutics Market, by Country, 2017-2022 (US$ Mn)

TABLE 131 Europe Hospital Infection Therapeutics Market, by Country, 2023-2030 (US$ Mn)

TABLE 132 Germany Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 133 Germany Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 134 Germany Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 135 Germany Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 136 Germany Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 137 Germany Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 138 Germany Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 139 Germany Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 140 Germany Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 141 Germany Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 142 Germany Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 143 Germany Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 144 Germany Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 145 Germany Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 146 Germany Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 147 Germany Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 148 France Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 149 France Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 150 France Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 151 France Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 152 France Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 153 France Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 154 France Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 155 France Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 156 France Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 157 France Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 158 France Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 159 France Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 160 France Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 161 France Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 162 France Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 163 France Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 164 United Kingdom Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 165 United Kingdom Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 166 United Kingdom Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 167 United Kingdom Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 168 United Kingdom Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 169 United Kingdom Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 170 United Kingdom Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 171 United Kingdom Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 172 United Kingdom Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 173 United Kingdom Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 174 United Kingdom Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 175 United Kingdom Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 176 United Kingdom Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 177 United KingdomHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 178 United KingdomHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 179 United KingdomHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 180 Italy Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 181 Italy Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 182 Italy Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 183 Italy Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 184 Italy Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 185 Italy Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 186 ItalyHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 187 ItalyHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 188 ItalyHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 189 ItalyHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 190 ItalyHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 191 ItalyHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 192 ItalyHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 193 ItalyHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 194 ItalyHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 195 ItalyHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 196 Spain Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 197 Spain Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 198 Spain Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 199 Spain Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 200 Spain Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 201 Spain Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 202 SpainHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 203 SpainHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 204 SpainHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 205 SpainHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 206 SpainHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 207 SpainHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 208 SpainHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 209 SpainHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 210 SpainHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 211 SpainHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 212 BeneluxHospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 213 BeneluxHospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 214 BeneluxHospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 215 BeneluxHospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 216 BeneluxHospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 217 BeneluxHospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 218 BeneluxHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 219 BeneluxHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 220 BeneluxHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 221 BeneluxHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 222 BeneluxHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 223 BeneluxHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 224 BeneluxHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 225 BeneluxHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 226 BeneluxHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 227 BeneluxHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 228 RussiaHospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 229 RussiaHospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 230 RussiaHospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 231 RussiaHospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 232 RussiaHospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 233 RussiaHospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 234 RussiaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 235 RussiaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 236 RussiaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 237 RussiaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 238 RussiaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 239 RussiaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 240 RussiaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 241 RussiaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 242 RussiaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 243 RussiaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 244 Rest of Europe Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 245 Rest of Europe Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 246 Rest of Europe Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 247 Rest of Europe Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 248 Rest of Europe Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 249 Rest of Europe Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 250 Rest of EuropeHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 251 Rest of EuropeHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 252 Rest of EuropeHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 253 Rest of EuropeHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 254 Rest of EuropeHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 255 Rest of EuropeHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 256 Rest of EuropeHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 257 Rest of EuropeHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 258 Rest of EuropeHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 259 Rest of EuropeHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 260 Asia Pacific Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 261 Asia Pacific Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 262 Asia Pacific Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 263 Asia Pacific Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 264 Asia Pacific Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 265 Asia Pacific Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 266 Asia PacificHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 267 Asia PacificHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 268 Asia PacificHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 269 Asia PacificHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 270 Asia PacificHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 271 Asia PacificHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 272 Asia PacificHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 273 Asia PacificHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 274 Asia PacificHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 275 Asia PacificHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 276 China Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 277 China Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 278 China Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 279 China Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 280 China Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 281 China Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 282 ChinaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 283 ChinaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 284 ChinaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 285 ChinaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 286 ChinaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 287 ChinaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 288 ChinaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 289 ChinaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 290 ChinaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 291 ChinaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 292 Japan Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 293 Japan Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 294 Japan Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 295 Japan Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 296 Japan Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 297 Japan Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 298 JapanHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 299 JapanHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 300 JapanHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 301 JapanHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 302 JapanHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 303 JapanHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 304 JapanHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 305 JapanHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 306 JapanHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 307 JapanHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 308 India Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 309 India Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 310 India Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 311 India Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 312 India Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 313 India Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 314 IndiaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 315 IndiaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 316 IndiaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 317 IndiaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 318 IndiaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 319 IndiaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 320 IndiaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 321 IndiaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 322 IndiaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 323 IndiaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 324 South Korea Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 325 South Korea Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 326 South Korea Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 327 South Korea Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 328 South Korea Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 329 South Korea Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 330 South KoreaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 331 South KoreaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 332 South KoreaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 333 South KoreaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 334 South KoreaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 335 South KoreaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 336 South KoreaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 337 South KoreaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 338 South KoreaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 339 South KoreaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 340 South-East Asia Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 341 South-East Asia Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 342 South-East Asia Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 343 South-East Asia Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 344 South-East Asia Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 345 South-East Asia Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 346 South-East AsiaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 347 South-East AsiaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 348 South-East AsiaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 349 South-East AsiaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 350 South-East AsiaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 351 South-East AsiaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 352 South-East AsiaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 353 South-East AsiaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 354 South-East AsiaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 355 South-East AsiaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 356 Rest of Asia Pacific Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 357 Rest of Asia Pacific Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 358 Rest of Asia Pacific Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 359 Rest of Asia Pacific Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 360 Rest of Asia Pacific Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 361 Rest of Asia Pacific Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 362 Rest of Asia PacificHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 363 Rest of Asia PacificHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 364 Rest of Asia PacificHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 365 Rest of Asia PacificHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 366 Rest of Asia PacificHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 367 Rest of Asia PacificHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 368 Rest of Asia PacificHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 369 Rest of Asia PacificHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 370 Rest of Asia PacificHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 371 Rest of Asia PacificHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 372 Latin America Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 373 Latin America Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 374 Latin America Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 375 Latin America Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 376 Latin America Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 377 Latin America Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 378 Latin AmericaHospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 379 Latin AmericaHospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 380 Latin AmericaHospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 381 Latin AmericaHospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 382 Latin AmericaHospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 383 Latin AmericaHospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 384 Latin AmericaHospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 385 Latin AmericaHospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 386 Latin AmericaHospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 387 Latin AmericaHospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 388 Brazil Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 389 Brazil Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 390 Brazil Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 391 Brazil Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 392 Brazil Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 393 Brazil Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 394 Brazil Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 395 Brazil Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 396 Brazil Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 397 Brazil Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 398 Brazil Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 399 Brazil Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 400 Brazil Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 401 Brazil Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 402 Brazil Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 403 Brazil Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 404 Argentina Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 405 Argentina Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 406 Argentina Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 407 Argentina Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 408 Argentina Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 409 Argentina Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 410 Argentina Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 411 Argentina Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 412 Argentina Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 413 Argentina Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 414 Argentina Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 415 Argentina Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 416 Argentina Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 417 Argentina Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 418 Argentina Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 419 Argentina Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 420 Rest of Latin America Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 421 Rest of Latin America Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 422 Rest of Latin America Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 423 Rest of Latin America Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 424 Rest of Latin America Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 425 Rest of Latin America Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 426 Rest of Latin America Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 427 Rest of Latin America Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 428 Rest of Latin America Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 429 Rest of Latin America Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 430 Rest of Latin America Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 431 Rest of Latin America Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 432 Rest of Latin America Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 433 Rest of Latin America Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 434 Rest of Latin America Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 435 Rest of Latin America Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 436 Middle East Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 437 Middle East Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 438 Middle East Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 439 Middle East Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 440 Middle East Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 441 Middle East Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 442 Middle East Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 443 Middle East Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 444 Middle East Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 445 Middle East Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 446 Middle East Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 447 Middle East Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 448 Middle East Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 449 Middle East Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 450 Middle East Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 451 Middle East Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 452 UAE Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 453 UAE Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 454 UAE Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 455 UAE Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 456 UAE Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 457 UAE Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 458 UAE Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 459 UAE Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 460 UAE Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 461 UAE Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 462 UAE Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 463 UAE Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 464 UAE Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 465 UAE Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 466 UAE Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 467 UAE Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 468 Saudi Arabia Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 469 Saudi Arabia Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 470 Saudi Arabia Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 471 Saudi Arabia Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 472 Saudi Arabia Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 473 Saudi Arabia Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 474 Saudi Arabia Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 475 Saudi Arabia Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 476 Saudi Arabia Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 477 Saudi Arabia Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 478 Saudi Arabia Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 479 Saudi Arabia Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 480 Saudi Arabia Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 481 Saudi Arabia Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 482 Saudi Arabia Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 483 Saudi Arabia Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 484 Rest of Middle East Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 485 Rest of Middle East Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 486 Rest of Middle East Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 487 Rest of Middle East Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 488 Rest of Middle East Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 489 Rest of Middle East Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 490 Rest of Middle East Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 491 Rest of Middle East Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 492 Rest of Middle East Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 493 Rest of Middle East Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 494 Rest of Middle East Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 495 Rest of Middle East Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 496 Rest of Middle East Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 497 Rest of Middle East Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 498 Rest of Middle East Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 499 Rest of Middle East Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 500 Africa Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 501 Africa Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 502 Africa Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 503 Africa Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 504 Africa Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 505 Africa Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 506 Africa Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 507 Africa Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 508 Africa Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 509 Africa Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 510 Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 511 Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 512 Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 513 Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 514 Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 515 Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 516 South Africa Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 517 South Africa Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 518 South Africa Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 519 South Africa Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 520 South Africa Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 521 South Africa Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 522 South Africa Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 523 South Africa Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 524 South Africa Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 525 South Africa Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 526 South Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 527 South Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 528 South Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 529 South Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 530 South Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 531 South Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 532 Egypt Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 533 Egypt Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 534 Egypt Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 535 Egypt Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 536 Egypt Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 537 Egypt Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 538 Egypt Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 539 Egypt Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 540 Egypt Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 541 Egypt Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 542 Egypt Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 543 Egypt Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 544 Egypt Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 545 Egypt Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 546 Egypt Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 547 Egypt Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

TABLE 548 Rest of Africa Hospital Infection Therapeutics Market, by Infection Type, 2017-2022 (US$ Mn)

TABLE 549 Rest of Africa Hospital Infection Therapeutics Market, by Infection Type, 2023-2030 (US$ Mn)

TABLE 550 Rest of Africa Hospital Infection Therapeutics Market, By Treatment Type, 2017-2022 (US$ Mn)

TABLE 551 Rest of Africa Hospital Infection Therapeutics Market, By Treatment Type, 2023-2030 (US$ Mn)

TABLE 552 Rest of Africa Hospital Infection Therapeutics Market, by Route of Administration, 2017-2022 (US$ Mn)

TABLE 553 Rest of Africa Hospital Infection Therapeutics Market, by Route of Administration, 2023-2030 (US$ Mn)

TABLE 554 Rest of Africa Hospital Infection Therapeutics Market, by End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 555 Rest of Africa Hospital Infection Therapeutics Market, by End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 556 Rest of Africa Hospital Infection Therapeutics Market, by Infection Source, 2017-2022 (US$ Mn)

TABLE 557 Rest of Africa Hospital Infection Therapeutics Market, by Infection Source, 2023-2030 (US$ Mn)

TABLE 558 Rest of Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2017-2022 (US$ Mn)

TABLE 559 Rest of Africa Hospital Infection Therapeutics Market, by Pathogen Type, 2023-2030 (US$ Mn)

TABLE 560 Rest of Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 561 Rest of Africa Hospital Infection Therapeutics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 562 Rest of Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2017-2022 (US$ Mn)

TABLE 563 Rest of Africa Hospital Infection Therapeutics Market, by Distribution Channel, 2023-2030 (US$ Mn)

Frequently asked questions

What is the current size of the worldwide Hospital Infection Therapeutics Market?

In 2022, the global Hospital Infection Therapeutics Market is expected to be worth USD 10512.5 million.

What is the predicted growth rate of the Hospital Infection Therapeutics Market between 2023 and 2030?

The Hospital Infection Therapeutics Market is estimated to increase at a CAGR of 5.00% between 2023 and 2030, reaching USD 13111.4 Million in 2030.

Which segment has the most market share in terms of infection type?

Surgical Site Infections (SSIs) lead the hospital therapeutics market in 2022

Which distribution channel segment governs the market demand for Hospital Infection Therapeutics ?

Retail pharmacies have the highest market demand

Which end-users segment is the fastest growing segment in the market over the forecast period?

Outpatient Clinics have the highest compound annual growth rate (CAGR) in the industry

Which region is driving the Hospital Infection Therapeutics industry forward?

North America is expected to dominate the market in 2022, accounting for 40% of total revenue.

Who are the major players in the global Hospital Infection Therapeutics Market?

The top players include Merck & Co., Inc.; Pfizer Inc.; Bayer AG; GlaxoSmithKline Plc.; Daiichi Sankyo Company, Limited; AbbVie Inc.; Abbott Laboratories; F. Hoffmann-La Roche Ltd; and Allergan Plc.

What are the major market drivers of the Hospital Infection Therapeutics industry?

What are the major market restraints of the Hospital Infection Therapeutics industry?

The market’s main hurdles include the emergence of antibiotic resistance, the high cost of researching and manufacturing novel treatments, stringent regulatory regulations, and limited access to healthcare facilities in some countries.

What are the major market opportunities of the Hospital Infection Therapeutics industry?

Novel medicines and treatment techniques are being developed. Infection control solutions are in high demand, and The market potential is collaboration and partnerships between pharmaceutical firms and healthcare providers.

Purchase Options

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –